MEDICAL USE OF ANTIBODIES DIRECTED AGAINST HUMAN MATRIX METALLOPROTEINASES OR RELATED TISSUE PROTEINASES FOR THE TREATMENT OF ABNORMAL UTERINE BLEEDING AND ENDOMETRIOSIS

2003
OA: closed

Abstract

The invention relates to the field of metalloproteinases and their involvement in abnormal uterine bleeding or in endometriosis. The invention provides inhibitors of tissue proteinases or of metalloproteinases for preparing medicaments for treating or preventing bleeding disorders of the endometrium. More specific, these inhibitors are inhibitory antibodies against matrix metalloproteinases.

My notes (saved in your browser only)

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

europepmc
last seen: 2026-08-12T06:07:16.479679+00:00